121 related articles for article (PubMed ID: 25537635)
41. Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.
Razzolini F; Saladini F; Malincarne L; Vicenti I; Palladino N; Romano L; Francisci D; Zazzi M
J Clin Microbiol; 2008 Nov; 46(11):3856-9. PubMed ID: 18845824
[TBL] [Abstract][Full Text] [Related]
42. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window.
Mitsias PD; Lu M; Silver B; Morris D; Ewing JR; Daley S; Lewandowski C; Katramados A; Papamitsakis NI; Ebadian HB; Zhao Q; Soltanian-Zadeh H; Hearshen D; Patel SC; Chopp M
Neurology; 2005 Aug; 65(4):612-5. PubMed ID: 16116128
[TBL] [Abstract][Full Text] [Related]
43. [Autopsy case of intracranial telangiectasia].
Kaneko H; Okamura A; Nishida K; Watanabe M
No To Shinkei; 1971 Nov; 23(11):1381-7. PubMed ID: 5172044
[No Abstract] [Full Text] [Related]
44. Human immunodeficiency virus and the brain.
Glass JD; Johnson RT
Annu Rev Neurosci; 1996; 19():1-26. PubMed ID: 8833434
[TBL] [Abstract][Full Text] [Related]
45. HIV viral load monitoring in resource-limited regions: optional or necessary?
Calmy A; Ford N; Hirschel B; Reynolds SJ; Lynen L; Goemaere E; Garcia de la Vega F; Perrin L; Rodriguez W
Clin Infect Dis; 2007 Jan; 44(1):128-34. PubMed ID: 17143828
[TBL] [Abstract][Full Text] [Related]
46. An unjustifiably alarming report of a fatal case of retroviral rebound syndrome.
Angel-Moreno A; Perez-Arellano JL
Clin Infect Dis; 2006 Mar; 42(5):732-3; author reply 733. PubMed ID: 16447127
[No Abstract] [Full Text] [Related]
47. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults.
Bonkowsky J; Pavia A
Neurology; 2007 Feb; 68(8):623; author reply 623. PubMed ID: 17310042
[No Abstract] [Full Text] [Related]
48. Influenza A-associated stroke in a 4-year-old male.
Bell ML; Buchhalter JR
Pediatr Neurol; 2004 Jul; 31(1):56-8. PubMed ID: 15246494
[TBL] [Abstract][Full Text] [Related]
49. Vaccination and HIV-1 replication during highly active antiretroviral therapy.
Kroon FP; Beersma MF; Kroes AC; Groeneveld PH; van Dissel JT
AIDS; 1999 Jan; 13(1):135-6. PubMed ID: 10207556
[No Abstract] [Full Text] [Related]
50. Ischemic stroke related to intracranial branch atheromatous disease and comparison with large and small artery diseases.
Kwan MW; Mak W; Cheung RT; Ho SL
J Neurol Sci; 2011 Apr; 303(1-2):80-4. PubMed ID: 21277587
[TBL] [Abstract][Full Text] [Related]
51. Heparin reduces proliferative angiopathy following subarachnoid hemorrhage in cats.
Kapp JP; Clower BR; Azar FM; Yabuno N; Smith RR
J Neurosurg; 1985 Apr; 62(4):570-5. PubMed ID: 3973727
[TBL] [Abstract][Full Text] [Related]
52. An unusual case of paradoxical embolism in a young patient affected by stroke.
De Santis G; Lattuada P; D'Arrigo G; Frediani F
Neurol Sci; 2015 Feb; 36(2):335-7. PubMed ID: 25034187
[No Abstract] [Full Text] [Related]
53. Spontaneous thrombosis of cerebral aneurysms presenting with ischemic stroke.
Cohen JE; Itshayek E; Gomori JM; Grigoriadis S; Raphaeli G; Spektor S; Rajz G
J Neurol Sci; 2007 Mar; 254(1-2):95-8. PubMed ID: 17258773
[TBL] [Abstract][Full Text] [Related]
54. Viral load and combination therapy for human immunodeficiency virus.
Srinivasan V; Beidas SO
N Engl J Med; 1997 Mar; 336(13):960; author reply 961. PubMed ID: 9072699
[No Abstract] [Full Text] [Related]
55. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
[TBL] [Abstract][Full Text] [Related]
56. Cerebral microbleeds in patients with acute subarachnoid hemorrhage.
Jeon SB; Parikh G; Choi HA; Badjatia N; Lee K; Schmidt JM; Lantigua H; Connolly ES; Mayer SA; Claassen J
Neurosurgery; 2014 Feb; 74(2):176-81; discussion 181. PubMed ID: 24176956
[TBL] [Abstract][Full Text] [Related]
57. [Histopathological studies of peripheral arteries in the brain associated with subarachnoid hemorrhage].
Negishi K
Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):171-81. PubMed ID: 6736210
[No Abstract] [Full Text] [Related]
58. HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?
Marra CM
Antivir Ther; 2015; 20(4):365-7. PubMed ID: 25781980
[TBL] [Abstract][Full Text] [Related]
59. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
Kofoed K; Gerstoft J; Mathiesen LR; Benfield T
Sex Transm Dis; 2006 Mar; 33(3):143-8. PubMed ID: 16505739
[TBL] [Abstract][Full Text] [Related]
60. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
